Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 2159Session 2025-2026

Exempting law enforcement agencies who do not provide emergency opioid antagonistspursuant to the statewide protocol from the requirement to procure a physician medical director.

As Introduced

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. HB 2159›
    2. HB 2159 — As Introduced

    Kansas Legislature

    HB 2159 — As Introduced

    picture_as_pdf Download PDF Session of 2025HOUSE BILL No. 2159By Representatives Proctor and Hoheisel1-301AN ACT concerning law enforcement; relating to emergency opioid 2antagonists; creating the emergency opioid antagonists assistance grant 3fund to assist law enforcement agencies with purchasing emergency 4opioid antagonists; maintaining immunity for law enforcement agencies 5and officers for damages resulting from administering an emergency 6opioid antagonist; removing law enforcement agencies and officers 7from the state board of pharmacy's statewide opioid antagonist 8protocol; amending K.S.A. 2024 Supp. 65-16,127 and repealing the 9existing section.1011Be it enacted by the Legislature of the State of Kansas:12New Section 1. (a) There is hereby established in the state treasury 13the emergency opioid antagonists assistance grant fund, to be administered 14by the attorney general. All moneys credited to the fund shall be for 15providing assistance to law enforcement agencies across the state in 16purchasing emergency opioid antagonists.17(2) All expenditures from the emergency opioid antagonists 18assistance account grant fund shall be made in accordance with 19appropriation acts upon warrants of the director of accounts and reports 20issued pursuant to vouchers approved by the attorney general or the 21attorney general's designee.22(c) The attorney general shall develop and implement the emergency 23opioid antagonists assistance grant program with the goal of providing 24assistance to law enforcement agencies across the state in purchasing 25emergency opioid antagonists for law enforcement officers to carry while 26such officers are on duty. Prioritization of emergency opioid antagonists 27assistance grant fund moneys shall be given to small law enforcement 28agencies. Only a law enforcement agency that has adopted a policy 29requiring the administration of emergency opioid antagonists shall be 30eligible to receive a grant pursuant to this subsection.31(d) On July 1, 2025, and on July 1 of each year thereafter, the director 32of accounts and reports shall transfer $4,000,000 from the state general 33fund to the emergency opioid antagonist assistance grant fund.34Sec. 2. K.S.A. 2024 Supp. 65-16,127 is hereby amended to read as 35follows: 65-16,127. (a) As used in this section:36(1) "Bystander" means a family member, friend, caregiver or other 1person in a position to assist a person who the family member, friend, 2caregiver or other person believes, in good faith, to be experiencing an 3opioid overdose.4(2) "Emergency opioid antagonist" means any drug that inhibits the 5effects of opioids and that is approved by the United States food and drug 6administration for the treatment of an opioid overdose.7(3) (A) "First responder" includes any emergency medical service 8provider, as defined by K.S.A. 65-6112, and amendments thereto, any law 9enforcement officer, as defined by K.S.A. 22-2202, and amendments 10thereto, and any actual member of any organized fire department, whether 11regular or volunteer.12(B) "First responder" does not include any law enforcement officer, 13as defined in K.S.A. 22-2202, and amendments thereto.14(4) (A) "First responder agency" includes, but is not limited to, any 15law enforcement agency, fire department or criminal forensic laboratory of 16any city, county or the state of Kansas.17(B) "First responder agency" does not include any law enforcement 18agency.19(5) "Opioid antagonist protocol" means the protocol established by 20the state board of pharmacy pursuant to subsection (b).21(6) "Opioid overdose" means an acute condition including, but not 22limited to, extreme physical illness, decreased level of consciousness, 23respiratory depression, coma, mania or death, resulting from the 24consumption or use of an opioid or another substance with which an 25opioid was combined, or that a layperson would reasonably believe to be 26resulting from the consumption or use of an opioid or another substance 27with which an opioid was combined, and for which medical assistance is 28required.29(7) "Patient" means a person believed to be at risk of experiencing an 30opioid overdose.31(8) "School nurse" means a professional nurse licensed by the board 32of nursing and employed by a school district to perform nursing 33procedures in a school setting.34(9) "Healthcare provider" means a physician licensed to practice 35medicine and surgery by the state board of healing arts, a licensed dentist, 36a mid-level practitioner as defined by K.S.A. 65-1626, and amendments 37thereto, or any person authorized by law to prescribe medication.38(b) The state board of pharmacy shall issue a statewide opioid 39antagonist protocol that establishes requirements for a licensed pharmacist 40to dispense emergency opioid antagonists to a person pursuant to this 41section. The opioid antagonist protocol shall include procedures to ensure 42accurate recordkeeping and education of the person to whom the 43emergency opioid antagonist is furnished, including, but not limited to: 1Opioid overdose prevention, recognition and response; safe administration 2of an emergency opioid antagonist; potential side effects or adverse events 3that may occur as a result of administering an emergency opioid 4antagonist; a requirement that the administering person immediately 5contact emergency medical services for a patient; and the availability of 6drug treatment programs.7(c) A pharmacist may furnish an emergency opioid antagonist to a 8patient or bystander subject to the requirements of this section, the 9pharmacy act of the state of Kansas and any rules and regulations adopted 10by the state board of pharmacy thereunder.11(d) A pharmacist furnishing an emergency opioid antagonist pursuant 12to this section may not permit the person to whom the emergency opioid 13antagonist is furnished to waive any consultation required by this section 14or any rules and regulations adopted thereunder.15(e) Any first responder, scientist or technician operating under a first 16responder agency or school nurse is authorized to possess, store, distribute 17and administer emergency opioid antagonists as clinically indicated, 18provided that all personnel with access to emergency opioid antagonists 19are trained, at a minimum, on the following:20(1) Techniques to recognize signs of an opioid overdose;21(2) standards and procedures to store, distribute and administer an 22emergency opioid antagonist;23(3) emergency follow-up procedures, including the requirement to 24summon emergency ambulance services either immediately before or 25immediately after administering an emergency opioid antagonist to a 26patient; and27(4) inventory requirements and reporting any administration of an 28emergency opioid antagonist to a healthcare provider.29(f) (1) Any first responder agency electing to provide an emergency 30opioid antagonist to its employees or volunteers for the purpose of 31administering the emergency opioid antagonist shall procure the services 32of a physician to serve as physician medical director for the first responder 33agency's emergency opioid antagonist program.34(2) The first responder agency shall utilize the physician medical 35director or a licensed pharmacist for the purposes of:36(A) Obtaining a supply of emergency opioid antagonists;37(B) receiving assistance developing necessary policies and 38procedures that comply with this section and any rules and regulations 39adopted thereunder;40(C) training personnel; and41(D) coordinating agency activities with local emergency ambulance 42services and medical directors to provide quality assurance activities.43(g) (1) Any healthcare provider or pharmacist who, in good faith and 1with reasonable care, prescribes or dispenses an emergency opioid 2antagonist pursuant to this section shall not, by an act or omission, be 3subject to civil liability, criminal prosecution or any disciplinary or other 4adverse action by a professional licensure entity arising from the 5healthcare provider or pharmacist prescribing or dispensing the emergency 6opioid antagonist.7(2) Any patient, bystander, school nurse, or a first responder, scientist 8or technician operating under a first responder agency, who, in good faith 9and with reasonable care, receives and administers an emergency opioid 10antagonist pursuant to this section to a person experiencing a suspected 11opioid overdose shall not, by an act or omission, be subject to civil liability 12or criminal prosecution, unless personal injury results from the gross 13negligence or willful or wanton misconduct in the administration of the 14emergency opioid antagonist.15(3) Any first responder agency employing or contracting any person 16that, in good faith and with reasonable care, administers an emergency 17opioid antagonist pursuant to this section to a person experiencing a 18suspected opioid overdose shall not, by an act or omission, be subject to 19civil liability, criminal prosecution, any disciplinary or other adverse 20action by a professional licensure entity or any professional review.21(4) Any law enforcement officer, as defined in K.S.A. 22-2202, and 22amendments thereto, or law enforcement agency employing or contracting 23with any person who, in good faith and with reasonable care, administers 24an emergency opioid antagonist to a person experiencing a suspected 25opioid overdose shall not, by an act or omission, be subject to civil 26liability, criminal prosecution, any disciplinary or other adverse action by 27a professional licensure entity or any professional review.28(h) The state board of pharmacy shall adopt rules and regulations as 29may be necessary to implement the provisions of this section prior to 30January 1, 2018.31(i) This section shall be a part of and supplemental to the pharmacy 32act of the state of Kansas.33Sec. 3. K.S.A. 2024 Supp. 65-16,127 is hereby repealed.34Sec. 4. This act shall take effect and be in force from and after its 35publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 Page 3 Page 4 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 1:21 AM 11/14/2026

    Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.